Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-30
2011-08-30
Sznaidman, Marcos (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S222800, C514S250000, C544S346000, C544S361000
Reexamination Certificate
active
08008287
ABSTRACT:
Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
REFERENCES:
patent: 4816570 (1989-03-01), Farquhar
patent: 4968788 (1990-11-01), Farquhar
patent: 5663159 (1997-09-01), Starrett, Jr. et al.
patent: 5683999 (1997-11-01), Jadhav et al.
patent: 5792756 (1998-08-01), Starrett, Jr. et al.
patent: 6245806 (2001-06-01), Dombrowski et al.
patent: 6271402 (2001-08-01), Singh et al.
patent: 6312662 (2001-11-01), Erion et al.
patent: 6395743 (2002-05-01), Heimbuch et al.
patent: 2003/0055071 (2003-03-01), Anthony et al.
patent: WO-91/19721 (1991-12-01), None
patent: WO-96/15111 (1996-05-01), None
patent: WO-99/62513 (1999-12-01), None
patent: WO-99/62520 (1999-12-01), None
patent: WO-00/39086 (2000-07-01), None
patent: WO-00/75122 (2000-12-01), None
patent: WO-01/00578 (2001-01-01), None
patent: WO-02/30426 (2002-04-01), None
patent: WO-02/30930 (2002-04-01), None
patent: WO-02/30931 (2002-04-01), None
patent: WO-02/36734 (2002-05-01), None
patent: WO-02/055079 (2002-07-01), None
patent: WO-2004/035576 (2004-04-01), None
patent: WO 2004/035577 (2004-04-01), None
patent: WO-2004/035577 (2004-04-01), None
patent: WO-2004/096807 (2004-11-01), None
patent: WO-2005/016927 (2005-02-01), None
patent: WO-2005/075475 (2005-08-01), None
patent: WO-2005/117904 (2005-12-01), None
patent: WO-2006/125048 (2006-11-01), None
patent: WO-2007/076005 (2007-07-01), None
Verschueren, W. et al. (2005) “Design and Optimization of Tricyclic Phtalimide Analogues as Novel Inhibitors of HIV-1 Integrase” J. Med. Chem 48:1930-1940.
Daelemans, D. et al. (2007) “Characterization of a Replication-Competent, Integrase-Defective Human Immunodeficiency Virus (HIV)/Simian Virus 40 Chimera as a Powerful Tool for the Discovery and Validation of HIV Integrase Inhibitors” J. of Vir. 81 (8): 4381-4385.
Anan'eva et al. (1983) “(2-lodoethyl) Phosphonic Derivatives,”Zhurnal Obshchei Khimii53(3):554-559.
Artico et al. (1998) “Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular Modeling,”J. Med. Chem. 41:3948-3960.
Asante-Appiah et al. (1999) “HIV-1 Integrase: Structural Organization, Conformational Changes, and Catalysis,”Advances in Virus Research52:351-363.
Benzaria et al. (1996) “Synthesis, in Vitro Antiviral Evaluation, and Stability Studies of Bis(S-acyl-2-thioethyl) Ester Derivatives of 9-2-(Phosphonomethoxy)ethyl)adenine (PMEA) as Potential PMEA Prodrugs with Improved Oral Bioavailability,”J. Med. Chem. 39:4958-4965.
Bhuta et al. (1980) “Analogues of Chloramphenicol: Circular Dichroism Spectra, Inhibition of Ribosomal Peptidyltransferase, and Possible Mechanism of Action,”J. Med. Chem. 23:1299-1305.
Buolamwini et al. (2002) “CoMFA and CoMSIA 3D QSAR and Docking Studies on Conformationally-Restrained Cinnamoyl HIV-1 Integrase Inhibitors: Exploration of a Binding Mode at the Active Site,”J. Med. Chem. 45:841-852.
Campagne et al. (1995) “1H-Benzotriazol-1-yloxy)tris(dimethylamino)phorphonium Hexafluorophosphate- and (1H-Benzotriazol-1-yloxy)tripyrroludinophosphonium Hexafluorophosphate-Mediated Activation of Monophosphonate Esters: Synthesis of Mixed Phosphonate Diesters, the Reactivity of the Benzotriazolyl Phosphonic Esters vs the Reactivity of the Benzotriazolyl Carboxylic Esters,”J. Org. Chem. 60:5214-5223.
Chen et al. (1997) “Design, Synthesis, and Biochemical Evaluation of Phosphonate and Phosphonamidate Analogs of Glutathionylspermidine as Inhibitors of Glutathionylspermidine Synthetase/Amidase fromEscherichia coli,”J. Med. Chem. 40:3842-3850.
Darby, G. (1995) “In Search of the Perfect Antiviral,”Antiviral Chemistry&Chemotherapy6(Suppl. 1):54-63.
Davies et al. (1988) “Dinucleotide Analogues as Inhibitors of Thymidine Kinase, Thymidylate Kinase, and Ribonucleotide Reductase,”J. Med. Chem. 31:1305-1308.
De Lombaert et aI. (1994) “N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors,”J. Med. Chem. 37:498-511.
Espeseth et al. (2000) “HIV-1 Integrase Inhibitors that Compete with the Target DNA Substrate Define a Unique Strand Transfer Conformation for Integrase,”PNAS97(21):11244-11249.
Farnet et al. (1996) “Differential Inhibtion of HIV-1 Preintegration Complexes and Purified Integrase Protein by Small Molecules,”Proc. Natl. Acad. Sci. USA93:9742-9747.
Farquhar et al. (1983) “Biologically Reversible Phosphate-Protective Groups,”Journal of Pharmaceutical Sciences72(3):324-325.
Galeotti et al. (1996) “A Straightforward Synthesis of α-Amino Phosphonate Monoesters Using BroP or TPyCIU,”Tetrahedron Letters37(23):3997-3998.
Goldgur et al. (1999) “Structure of the HIV-1 Integrase Catalytic Domain Complexed with an Inhibitor: A Platform for Antiviral Drug Design,”PNAS96(23):13040-13043.
Hazuda et al. (1994) “A Novel Assay for the DNA Strand-Transfer Reaction of HIV-1 Integrase,”Nucleic Acids Research22(6):1121-1122.
Hazuda et al. (1997) “Differential Divalent Cation Requirements Uncouple the Assembly and Catalytic Reactions of Human Immunodeficiency Virus Type I Intergrase,”Journal of Virology71(9):7005-7011.
Hazuda et al. (1997) “Discovery and Analysis of Inhibitors of the Human Immunodeficiency Integrase,”Drug Design and Discovery15:17-24.
Hazuda et al. (2000) “Inhibitors of Strand Transfer that Prevent Integration and Inhibit HIV-1 Replication in Cells,”Science287:646-650.
Jacob, P. III (1982) “Resolution of -5-Bromonornicotine. Synthesis of (R)- and (S)- Nornicotine of High Enantiomeric Purity,”J. Org. Chem. 47:4165-4167.
Jing et al. (2002) “Potassium-Dependent Folding: A Key to Intracellular Delivery of G-Quartet Oligonucleotides as HIV Inhibitors,”Biochemistry41:5397-5403.
Katzman et al. (1999) “Substrate Recognition by Retroviral Integrases,”Advances in Virus Research52:371-395.
Khamnei et al. (1996) “Neighboring Group Catalysis in the Design of Nucleotide Prodrugs,”J. Med. Chem. 39:4109-4115.
Lafemina et al. (1992) “Requirement of Active Human Immunodeficiency Virus-Type 1 Integrase Enzyme for Productive Infection of Human T-Lymphoid Cells,”Journal of Virology66(12):7414-7419.
Le Bas et al. (2001) “Oxidation of 2-and 3-Halogenated Quinolines: An Easy Access to 5- and 6-Halogenopyridine-2,3-dicarboxylic Acids,”Synthesis16:2495-2499.
Lochmuller, C. (1975) “Chromatographic Resolution of Enantiomers Selective Review,”Journal of Chromatography113:283-302.
Mikhailopulo et al. (2000) “Pyrophosphoryl, Derivatives of 1-(2-Deoxy-3-O Phosphonomethyl -β-and -α-D-erythro-Pentofuranosyl)Thymine: Synthesis and Substrate Properties Towards Some DNA Polymerases,”Nucleosides, Nucleotides & Nucleic Acids19(10-12):1885-1909.
Mitchell et al. (1992) “Bioreversible Protection for the Phospho Group: Bioactivation of the Di-(4-acyloxybenzyl) and Mono(4-acyloxybenzyl) Phosphoesters of Methylphosphonate and Phosphonoacetate,”J. Chem. Soc. Perkin Trans. I2345-2353.
Morgan et al. (1994) “Structure-Based Design of an Inhibitor of the Zinc Peptidase Thermolysin,”J. Am. Chem. Soc. 116:3251-3260.
Musiol et al. (1994) “On the Synthesis of Phosphonamidate Peptides,”J. Org. Chem. 59:6144-6146.
Nair, V. (2002) “HIV Integrase as a Target for Antiviral Chemotherapy,”Rev. Med. Virol. 12:179-193.
Okamoto et al. (1990) “Optical Resolution of Dihydropyridine Enantiomers by High-Perfomance Liquid Chromatography Using Phenylcarbamates of Polysaccharides as a Chiral Stationary Phase,”Journal of Chromatography513:375-378.
Pais et al. (2002) “Structure Activity of 3-Aryl-1-1,3-diketo-Containing Compounds as HIV-1 Integra
Cai Zhenhong R.
Jabri Salman Y.
Jin Haolun
Lansdown Rachael A.
Metobo Samuel E.
Gilead Sciences, Inc.
Sznaidman Marcos
Voelk Eric K.
LandOfFree
Integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702487